QA: Molecular Templates Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001183765_2020_Molecular_Templates_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001183765, Molecular Templates Inc

  xvar xval
0 AssetsCurrent 139,899,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 18,158,000
3 remainder_Assets 16,145,000
4 LiabilitiesCurrent 35,801,000
5 LiabilitiesNoncurrent 15,988,000
6 remainder_Liabilities 19,385,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,987,903
9 ResearchAndDevelopmentExpense 43,426,024
10 remainder_Expenses 1,019,422
11 remainder_Revenues 34,662,377
12 remainder_NetIncome 525,667
13 remainder_ComprehensiveNetIncome 1,067,879
  yvar yval
0 Assets 174,202,000
1 Liabilities 71,174,000
2 Expenses 62,433,349
3 Revenues 34,662,377
4 StockholdersEquity 103,028,000
5 NetIncome -27,245,305
6 ComprehensiveNetIncome -26,711,366
7 BaseVar 172,032,636
8 EconomicCapitalRatiobeforeLimitedLiability 1.61
9 EconomicCapitalRatio 2.76

Edgar->Model Mapping

Feature Distribution

Change over Time